Stimulants pp 425-464 | Cite as

Nicotine and Smoking

  • Ellen R. Gritz
  • Murray E. Jarvik
Part of the Handbook of Psychopharmacology book series (HBKPS, volume 11)


What defines the allure of tobacco? Does it symbolize sin and man’s frailty as the ballad suggests? Or, as the psychoanalyst theorizes, does it represent an autoerotic behavior related to breast-feeding?


Cigarette Smoking Smoking Behavior Federal Trade Commission Arousal Level Chronic Nicotine 
These keywords were added by machine and not by the authors. This process is experimental and the keywords may be updated as the learning algorithm improves.


Unable to display preview. Download preview PDF.

Unable to display preview. Download preview PDF.


  1. Altman, J. L., Meyer, R. E., Mirin, S. M., and McNamee, H. B., 1974, The Effects of Narcotic Antagonists upon Heroin Self-Administration Behavior, Report of the 36th Annual Scientific Meeting, Committee on Problems of Drug Dependence, National Academy of Sciences, pp. 752-763.Google Scholar
  2. Anand, C. L., 1971, Effect of Avena sativa on cigarette smoking, Nature 233:496.PubMedGoogle Scholar
  3. Andersson, K., 1975, Effects of cigarette smoking on learning and retention, Psychopharmacologia 41:1–5.PubMedGoogle Scholar
  4. Ashton, H., and Watson, D. W., 1970, Puffing frequency and nicotine intake in cigarette smokers, Brit. Med. J., 3:679–681.PubMedGoogle Scholar
  5. Beckett, A. H., Gorrod, J. W., and Jenner, P., 1971, The analysis of nicotine-1′-N-oxide in urine in the presence of nicotine and cotinine, and its application to the study of in vivo nicotine metabolism in man J. Pharm. Pharmacol. 23:55S–61S.PubMedGoogle Scholar
  6. Bernstein, D. A., 1970, The modification of smoking behavior. An evaluative review, in Learning Mechanisms in Smoking, (W. A. Hunt, ed.), pp. 3-41, Chicago.Google Scholar
  7. @@Boston Collaborative Drug Surveillance Program, Boston University Medical Center, 1973, Clinical depression of the central nervous system due to diazepam and chlordiazepoxide in relation to cigarette smoking and age, New End. J. Med. 288:277–280.Google Scholar
  8. Bovet-Nitti, F., 1969, Facilitation of simultaneous visual discrimination by nicotine in four “inbred” strains of mice, Psychopharmacologia 14:193–199.PubMedGoogle Scholar
  9. Bradshaw, P. W., 1973, The problem of cigarette smoking and its control, Int. J. Addict. 8:353–371.PubMedGoogle Scholar
  10. Brantmark, B., Ohlin, P., and Westling, H., 1973, Nicotine-containing chewing gum as an anti-smoking aid, Psychopharmacologia 31:181–200.Google Scholar
  11. Brecher, E. M., 1972, Licit and Illicit Drugs, Little, Brown, Boston.Google Scholar
  12. Davison, G. C., and Rosen, R. C., 1972, Lobeline and reduction of cigarette smoking, Psych. Rep. 31:443–456.Google Scholar
  13. Deneau, G. A., and Inoki, R., 1967, Nicotine self-administration in monkeys, Ann. N.Y. Acad. Sci. 142:277–279.Google Scholar
  14. DHEW, 1974, Tar and Nicotine Content of Cigarettes, Federal Trade Commission, Department of Health, Education and Welfare, Publ. No. (CDC) 74-8703.Google Scholar
  15. DHEW, 1972, 1974, Teenage Smoking, National Patterns of Cigarette Smoking, Ages 12 through 18, in 1972 and 1974, Department of Health, Education and Welfare, Public Health Service, DHEW Publication No. (NIH) 76-931.Google Scholar
  16. Domino, E. F., and von Baumgarten, A. M., 1959, Tobacco cigarette smoking and patellar reflex depression, Clin. Pharmacol. Ther. 10:72–79.Google Scholar
  17. Ejrup, B., 1963, Experience in smoking withdrawal clinics, American Cancer Society News Service, pp. 1-7.Google Scholar
  18. Eysenck, H. J., 1973, Personality and the maintenance of the smoking habit, in Smoking Behavior: Motives and Incentives (W. L. Dunn, Jr., ed.), pp. 113–146, V. H. Winston & Sons, Washington D. C.Google Scholar
  19. Federal Trade Commission, 1975, Tar and Nicotine Content of Cigarettes, DHEW Publication No. (CDC) 74-8703.Google Scholar
  20. Fee, W. M., 1972, Methods of treating cigarette smokers (results and experiences), Rehabilitation (Bonn) 25:89–90.Google Scholar
  21. Fee, W. M., and Benson, C., 1971, Group therapy: a review of six years’ experience in a Scottish anti-smoking clinic, Community Med. 126:361–364.Google Scholar
  22. Ferno, O., 1973, A substitute for tobacco-smoking, Psychopharmacologia 31:201–204.PubMedGoogle Scholar
  23. Frankenhaeuser, M., Myrsten, A. L., Post, B., and Johansson, G., 1971, Behavioral and physiological effects of cigarette smoking in a monotonous situation, Psychopharmacologia 22:1–7.PubMedGoogle Scholar
  24. Frith, C. D., 1968, The effects of nicotine on the consolidation of pursuit rotor learning, Life Sci. 7:77–84.PubMedGoogle Scholar
  25. Frith, C. D., 1971, The effect of varying the nicotine content of cigarettes on human smoking behavior, Psychopharmacologia 19:188–192.PubMedGoogle Scholar
  26. Fuller, R. G. C., and Forrest, D. W., 1973, Behavioral aspects of cigarette smoking in relation to arousal level, Psych. Rep. 33:115–121.Google Scholar
  27. Gallup Poll, 1976, Commissioned by the American Cancer Society.Google Scholar
  28. Garg, M., 1969, The effect of nicotine on two different types of learning, Psychopharmacologia 15:408–414.PubMedGoogle Scholar
  29. Geckeler, K., Schmidt, K., and Schmidt, F., 1974, Placebo-effect of aids for stopping of smoking, Munch. Med. Wochenschr. 116:581–582.Google Scholar
  30. Goldfarb, T. L., and Jarvik, M. E., 1972, Accommodation to restricted tobacco smoke intake in cigarette smokers, Int. J. Addict. 7:559–565.PubMedGoogle Scholar
  31. Goldfarb, T. L., Jarvik, M. E., and Glick, S. D., 1970, Cigarette nicotine content as a determinant of human smoking behavior, Psychopharmacologia 17:89–93.PubMedGoogle Scholar
  32. Golledge, A. H., 1965, Influencing factors in anti-smoking clinics, The Medical Officer 114:59–61.Google Scholar
  33. Gorrod, J. W., and Jenner, P., 1975, The metabolism of tobacco alkaloids, in Essays in Toxicology, Vol. 6 (W. J. Hayes, Jr., ed.), pp. 35–78, Academic Press, New York.Google Scholar
  34. Gritz, E. R., and Jarvik, M. E., 1973, A preliminary study: forty-eight hours of abstinence from smoking, Proc. Annu. Conv. Am. Psych. Assoc. 81st 1:1039–1040.Google Scholar
  35. Gritz, E. R., Shiffman, S. M., Jarvik, M. E., Haber, J., Dymond, A. M., Coger, R., Charuvastra, V., and Schlesinger, J., 1975, Physiological and psychological effects of methadone in man, Arch. Gen. Psych. 32:237–242.Google Scholar
  36. Gritz, E. R., Baer-Weiss, V., and Jarvik, M. E., 1976a, Titration of nicotine intake with full-length and half-length cigarettes, Clin. Pharmacol. Ther. 20:552–556.PubMedGoogle Scholar
  37. Gritz, E. R., Shiffman, S. M., Jarvik, M. E., Schlesinger, J., and Charuvastra, V. C., 1976, Naltrexone: as assessment of physiological and psychological effects in single doses, Clin. Pharmacol. Ther. 19:773–776.PubMedGoogle Scholar
  38. Guilford, J. S., 1966, Factors Related to Successful Abstinence from Smoking, American Institutes for Research, Pittsburgh.Google Scholar
  39. Hammett, V. B., and Graff, H., 1966, Therapy of smoking, Curr. Psych. Ther. 6:70–75.Google Scholar
  40. Hammond, E. C., 1966, Smoking in relation to the death rates of one million men and women, in Epidemiological Approaches to the Study of Cancer and Other Chronic Diseases, U.S. Public Health Service, Bethesda, Maryland, National Cancer Institute Monograph No. 19, January, pp. 127–204.Google Scholar
  41. Hauser, R., 1974, Rapid smoking as a technique of behavior modification, J. Consult. Clin. Psychol. 42:625–626.PubMedGoogle Scholar
  42. Heimstra, N. W., 1973, The effect of smoking on mood change, in Smoking Behavior: Motives and Incentives (W. L. Dunn, Jr., ed.), pp. 197–208, V. H. Winston & Sons., Washington, D. C.Google Scholar
  43. Heyden, S., Wild, R., Escher, M., Bruderer, E., and Metzler, B., 1974, Smoking habits and smoking withdrawal in Swiss men, Schweiz. Med. Wochenschr. 104:800–804.PubMedGoogle Scholar
  44. Herxheimer, A., Griffiths, R. L., Hamilton, B., and Wakefield, M., 1967, Circulatory effects of nicotine aerosol inhalations and cigarette smoking in man, Lancet 2:754–755.PubMedGoogle Scholar
  45. Horn, D., 1969, Use of Tobacco, Report of the National Clearinghouse for Smoking and Health, U.S. Public Health Service, Department of Health, Education and Welfare.Google Scholar
  46. Horn, D., 1970, Adult use of Tobacco, Report of the National Clearinghouse for Smoking and Health, U.S. Public Health Service, Department of Health, Education and Welfare. Publication No. (HSM)73-8727.Google Scholar
  47. Hunt, W. A., and Bespalec, D. A., 1974, An evaluation of current methods of modifying smoking behavior, J. Clin. Psychol. 30:431–438.PubMedGoogle Scholar
  48. Hunt, W. A., and Matarazzo, J. D., 1973, Three years later: recent developments in the experimental modification of smoking behavior, J. Abnorm. Psychol. 81:107–114.PubMedGoogle Scholar
  49. Hunt, W. A., Barnett, L. W., and Branch, L. G., 1971, Relapse rates in addiction programs, J. Clin. Psychol. 27:455–456.PubMedGoogle Scholar
  50. Hutchinson, R. R., and Emley, G. S., 1973, Effects of nicotine on avoidance, conditioned suppression and aggression response measures in animals and man, in Smoking Behavior: Motives and Incentives (W. L. Dunn, Jr., ed.), pp. 171–196, V. H. Winston & Sons, Washington, D. C.Google Scholar
  51. Isaac, P. F., and Rand, M. J., 1972, Cigarette smoking and plasma levels of nicotine, Nature 236:308–310.PubMedGoogle Scholar
  52. Itil, T. M., Ulett, G. A., Hsu, W., Klingenberg, H., and Ulett, J. A., 1971, The effects of smoking withdrawal on quantitatively analyzed EEG, Clin. Electroencephalogr. 2:44–51.Google Scholar
  53. Jacobs, M. A., Spilken, A. Z., Norman, M. M., Wohlberg, G. W., and Knapp, P. H., 1971, Interaction of personality and treatment conditions associated with success in a smoking control program, Psychosomatic Medicine 33:545–556.PubMedGoogle Scholar
  54. Jaffe, J. H., 1975, Drug addiction and drug abuse, in The Pharmacological Basis of Therapeutics (L. S. Goodman and A. Gilman, eds.), 5th ed., pp. 284–325, MacMillan, New York.Google Scholar
  55. Jarvik, M. E., Glick, S. D., and Nakamura, R. K., 1970, Inhibition of cigarette smoking by orally administered nicotine, Clin. Pharmacol. Therap. 11:574–576.Google Scholar
  56. Jick, H., 1974, Smoking and clinical drug effects, Med. Clin. North. Am. 58:1143–1149.PubMedGoogle Scholar
  57. Johnston, L., 1942, Tobacco smoking and nicotine, Lancet 2:742.Google Scholar
  58. Keutzer, C. S., Lichtenstein, E., and Mees, H. L., 1968, Modification of smoking behavior: A review, Psychol. Bull. 70:520–533.PubMedGoogle Scholar
  59. Knapp, D. E., and Domino, E. F., 1962, Action of nicotine on the ascending reticular activating system, Int. J. Neuropharmacol. 1:333–351.Google Scholar
  60. Knapp, P., Bliss, C. M., and Wells, H., 1963, Addictive aspects in heavy cigarette smoking, Am. J. Psych. 119:966–972.Google Scholar
  61. Kozlowski, L. T., Jarvik, M. E., and Gritz, E. R., 1975, Nicotine regulation and cigarette smoking, Clin. Pharmacol. Therap. 17:93–97.Google Scholar
  62. Langone, J. J., Gjika, H. B., and Van Vunakis, H., 1973, Nicotine and its metabolites; radioimmunoassays for nicotine and cotinine, Biochemistry 12:5025–5030.PubMedGoogle Scholar
  63. Larson, P. S., and Silvette, H., 1968, Tobacco: Experimental and Clinical Studies. Supplement I, Williams and Wilkins, Baltimore.Google Scholar
  64. Larson, P. S., and Silvette, H., 1971, Tobacco: Experimental and Clinical Studies. Supplement I, Williams and Wilkins, Baltimore.Google Scholar
  65. Leone, L. A., Musiker, H. R., Albala, M. M., and McGurk, W., 1968, A study of the effectiveness of the smoking deterrence clinic, Rhode Island Med. J. 51:247–260.PubMedGoogle Scholar
  66. Lichtenstein, E., Harris, D., Birchler, G., Wahl, J., and Schmahl, D., 1973, Comparison of rapid smoking, warm smoky air, and attention placebo in the modification of smoking behavior, J. Consult. Clin. Psychol. 40:92–98.PubMedGoogle Scholar
  67. Lucchesi, B. R., Schuster, C. R., and Emley, G. S., 1967, The role of nicotine as a determinant of cigarette smoking frequency in man with observations of certain cardiovascular effects associated with tobacco alkaloid, Clin. Pharmacol. Therap. 8:789–796.Google Scholar
  68. McAlister, A., 1975, Helping people quit smoking: current progress, in Applying Behavioral Science to Cardiovascular Disease (A. Enelow, ed.), American Heart Association, New York.Google Scholar
  69. Marston, A. K., and McFall, R. M., 1971, Comparison of behavior modification approaches to smoking reduction, J. Consult. Psychol. 36:153–162.Google Scholar
  70. Martin, W. R., Jasinski, D. R., Haertzen, C. A., Kay, D. C., Hones, B. E., Mansky, P. A., and Carpenter, R. W., 1973a, Methadone—a reevaluation, Arch. Gen. Psych. 28:286–295.Google Scholar
  71. Martin, W. R., Jasinski, D. R., and Mansky, P. A., 1973b, Naltrexone, an antagonist for the treatment of heroin dependence, Arch. Gen. Psych. 28:784–791.Google Scholar
  72. Menninger, K., 1973, Whatever Became of Sin? Hawthorn, New York.Google Scholar
  73. Merck Index, 1968, 8th ed., Merck & Co., Inc., Rahway.Google Scholar
  74. Merry, J., and Preston, G., 1963, The effect of buffered lobeline sulphate on cigarette smoking, Practitioner 190:628–631.PubMedGoogle Scholar
  75. Miller, M. M., 1941, Benzedrine sulphate in the treatment of nicotinism, Med. Record. 153:137–138.Google Scholar
  76. Miller, N. E., 1973, General comments on problems of motivation relevant to smoking, in Smoking Behavior: Motives and Incentives (W. L. Dunn, Jr., ed.), pp. 209–214, V. H. Winston & Sons, Washington D. C.Google Scholar
  77. Modell, W., and Lansing, A., 1967, Drugs, p. 58, Time, Inc., New York.Google Scholar
  78. Morison, S. E., 1971, The European Discovery of America, the Northern Voyages, A.D. 500–1600, Oxford University Press, New York.Google Scholar
  79. Myrsten, A. L., and Elgerot, A., 1974, Effects of abstinence from tobacco smoking on physiological and psychological arousal level in habitual smokers, Reports from the Psychological Laboratories, Univ. of Stockholm, No. 428.Google Scholar
  80. Myrsten, A. L., Post, B., Frankenhaeuser, M., and Johansson, G., 1972, Changes in behavioral and physiological activation induced by cigarette smoking in habitual smokers, Psychopharmacologia 27:305–312.PubMedGoogle Scholar
  81. Myrsten, A. L., Andersson, K., Frankenhaeuser, M., and Elgerot, A., 1975, Immediate effects of cigarette smoking as related to different smoking habits. Percept. Mot. Skills, 40:515–523.PubMedGoogle Scholar
  82. Nelsen, J. M., Psychobiological consequences of chronic nicotinization: a focus on arousal, in The First International Workshop on the Behavioral Effects of Nicotine (K. Battig, ed.), S. Karger, Basel (in press).Google Scholar
  83. Nelsen, J. M., and Goldstein, L., 1972, Improvement of performance on an attention task with chronic nicotine treatment in rats, Psychopharmacologia 26:347–360.PubMedGoogle Scholar
  84. Nelsen, J. M., and Goldstein, L., 1973, Chronic nicotine treatment in rats: 1. Acquisition and performance of an attention task, Res. Comm. Chem. Pathol. Pharmacol. 5:681–693.Google Scholar
  85. Nelsen, J. M., Pelley, K., and Goldstein, L., 1973, Chronic nicotine treatment in rats: 2. Electroencephalographic amplitude and variability changes occurring within and between structures, Res. Commun. Chem. Pathol. Pharmacol. 5:694–704.PubMedGoogle Scholar
  86. Nelson, J. M., Pelley, K., and Goldstein, L., 1975, Protection from behavioral disruption caused by reticular formation stimulation in the rat, Pharmacol. Biochem. Behav. 3:749–754.Google Scholar
  87. Oldendorf, W. H., 1977, Distribution of drugs in the brain, in Psychopharmacology in the Practice of Medicine (M. E. Jarvik, ed.), pp. 169–178, Appleton-Century-Crofts, New York.Google Scholar
  88. Olds, M. E., and Domino, E. F., 1969, Differential effects of cholinergic agonists on self-stimulation and escape behavior, J. Pharmacol. Exp. Ther. 170:157–167.PubMedGoogle Scholar
  89. Pantuck, E. J., Hsiao, M. S., Maggio, B. S., Nakamura, K., Kuntzman, R., and Conney, A. H., 1974, Effect of cigarette smoking on phenacetin metabolism, Clin. Pharmacol. Therap. 15:9–17.Google Scholar
  90. Roazen, P., 1975, Freud and His Followers, Alfred A. Knopf, New York.Google Scholar
  91. Rosenberg, A., 1972, The principle in anti-smoking cure and introduction to measuring carbon monoxide, Rehabilitation (Bonn) 25:90–93.Google Scholar
  92. Rosnick, M. J., 1965, The smoking deterrent effect of a new lobeline dosage form, J. Florida Med. Assoc. 52:27–30.Google Scholar
  93. Ross, C. A., 1967, Smoking withdrawal research clinics, Am. J. Public Health 57:677–681.Google Scholar
  94. Russell, M. A. H., 1971, Cigarette smoking: natural history of a dependence disorder, Br. J. Med. Psychol. 44:1–16.PubMedGoogle Scholar
  95. Russell, M. A. H., Wilson, C., Patel, U. A., Feyerabend, C., and Cole, P. V., 1975, Plasma nicotine levels after smoking cigarettes with high, medium and low nicotine yields, Br. Med. J. 6:414–416.Google Scholar
  96. Russell, M. A. H., Wilson, C., Feyerabend, C., and Cole, P. V., 1976, Effect of nicotine chewing gum on smoking behavior and as an aid to cigarette withdrawal, Br. Med. J. 6032:391–393.Google Scholar
  97. Ryan, F. J., 1973, Cold turkey in Greenfield, Iowa: A follow-up study, in Smoking Behavior: Motives and Incentives (W. L. Dunn, Jr., ed.), pp. 231–242, V. H. Winston & Sons, Washington, D. C.Google Scholar
  98. Scharfenberg, G., Winkelvoss, E., and Benndorf, S., 1967, Contribution to the problem of disaccustoming from smoking by medication with dihydrochlorothiazide (urodiazin), Munch. Med. Wochenschr. 109:1687–1690.PubMedGoogle Scholar
  99. Schauble, P. G., Woody, R. H., and Resnikoff, A., 1967, Educational therapy and withdrawal from smoking, J. Clin. Psychol. 23:518–519.PubMedGoogle Scholar
  100. Schmidt, F., 1966, Medicinal support of withdrawal from smoking by (di-)hydrochlorothiazide, Munch. Med. Wochenschr. 108:915–920.PubMedGoogle Scholar
  101. Schmidt, F., 1974, Medical support of nicotine withdrawal. A report on a double blind trial in over 5,000 smokers, Munch. Med. Wochenschr. 116:557–567.Google Scholar
  102. Schwartz, J. L., and Dubitzky, M., 1967, The smoking control research project: purpose, design and initial results, Psychol. Rep. 20:367–376.PubMedGoogle Scholar
  103. Schwartz, J. L., and Dubitzky, M., 1968, One-year follow-up results of a smoking cessation program, Can. J. Public Health 59:161–165.PubMedGoogle Scholar
  104. Scott, G. W., Cox, A. G. C., MacLean, K. S., Price, T. M. L., and Southwell, N., 1962, Buffered lobeline as a smoking deterrent, Lancet 1:54–55.Google Scholar
  105. Seely, J. E., Zuskin, E., and Bouhuys, A., 1971, Cigarette smoking: objective evidence for lung damage in teen-agers, Science 172:741–743.PubMedGoogle Scholar
  106. Shapiro, A. K., 1976, The behavior therapies: therapeutic breakthrough or latest fad? Am. J. Psych. 133:154–159.Google Scholar
  107. Shiffman, S. M., and Jarvik, M. E., 1976, Smoking withdrawal symptoms in two weeks of abstinence, Psychopharmacology, 50:35–39.PubMedGoogle Scholar
  108. Standord Research Institute, 1976, Study commissioned by the American Cancer Society.Google Scholar
  109. Stolerman, I. P., Fink, R., and Jarvik, M. E., 1973a, Acute and chronic tolerance to nicotine measured by activity in rats, Psychopharmacologia 30:329–342.PubMedGoogle Scholar
  110. Stolerman, I. P., Goldfarb, T., Fink, R., and Jarvik, M. E., 1973b, Influencing cigarette smoking with nicotine antagonists, Psychopharmacologia 28:247–259.PubMedGoogle Scholar
  111. Swett, C. R., 1974, Drowsiness due to chlorpromazine in relation to cigarette smoking, Arch. Gen. Psych. 31:211–214.Google Scholar
  112. Tomkins, S. S., 1966, Psychological model for smoking behavior, Am. J. Publid Health 56:17–20.Google Scholar
  113. Ulett, J. A., and Itil, T. M., 1969, Quantitative electroencephalogram in smoking and smoking deprivation, Science 164:969–970.PubMedGoogle Scholar
  114. United States Department of Health, Education and Welfare, Public Health Service, 1973, The Health Consequences of Smoking, Jan.Google Scholar
  115. United States Public Health Service, 1964, Smoking and Health, Report of the Advisory Committee to the Surgeon General of the Public Health Service, Publ. No. 1103.Google Scholar
  116. Volle, R. L., and Koelle, G. B., 1975, Ganglionic stimulating and blocking agents, in The Pharmacological Basis of Therapeutics, (L. S. Goodman and A. Gilman, eds.), 5th ed., pp. 565–575, Macmillan, New York.Google Scholar
  117. Wagner, S., 1971, Cigarette Country, Praeger, New York.Google Scholar
  118. Weiss, B., and Laties, V. G., 1962, Enhancement of human performance by caffeine and the amphetamines, Pharmacol. Rev. 14:115–116.Google Scholar
  119. Weybrew, B. B., and Stark, J. E., 1967, Psychological and physiological changes associated with deprivation from smoking, U.S. Naval Submarine and Medical Center Report, No. 490.Google Scholar
  120. Whitehead, R. W., and Davies, J. M., 1964, A study of methylphenidate and diazepam as possible smoking deterrents, Curr. Ther. Res. 6:363–367.PubMedGoogle Scholar
  121. Wilhelmsen, L., 1968, One year’s experience in an anti-smoking clinic, Scand. J. Respir. Dis. 49:251–259.PubMedGoogle Scholar
  122. Wise, C. D., and Stein, L., 1970, Amphetamine: facilitation of behavior by augmented release of norepinephrine from the medial forebrain bundle, in International Symposium on Amphetamines and Related Compounds (E. Costa and S. Gorattini, eds.), pp. 463–485, Raven Press, New York.Google Scholar

Copyright information

© Plenum Press, New York 1978

Authors and Affiliations

  • Ellen R. Gritz
    • 1
  • Murray E. Jarvik
    • 2
  1. 1.Veterans Administration Hospital Brentwood, and Department of PsychiatryUniversity of CaliforniaLos AngelesUSA
  2. 2.Veterans Administration Hospital Brentwood, and Departments of Psychiatry and PharmacologyUniversity of CaliforniaLos AngelesUSA

Personalised recommendations